-Reuters Cited Data Analyzed By Healthcare Research Firm 3 Axis Advisors
Drugmakers Including Pfizer, Sanofi And Takeda Plan To Raise Prices In The US On More Than 500 Unique Drugs In Early January
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.